Pharma major Dr. Reddy's Laboratories reported a marginal 2% year-on-year (YoY) growth in its consolidated net profit at Rs 1 ...

Number of schemes are being implemented to realise the vision of Atmanirbhar Bharat in the pharmaceutical sector and to ...

Phlow’s capital raise announcement came a day after Gov. Glenn Youngkin and British pharmaceutical firm AstraZeneca publicly ...

Sigachi Industries is set to strengthen its scientific and technical capabilities with the commencement of operations at its newly established R&D Center in Hyderabad.

Mass spectrometry is critical in drug discovery — but legacy systems, data silos, and poor metadata are slowing progress. This white paper, in partnership with Thermo Fisher, shares how experts from ...

With ₹700 crore in budgetary support, seven CoEs have been established at the National Institutes of Pharmaceutical Education ...

Hyderabad: Dr Reddy's Labs has announced that the Company has received the Establishment Inspection Report (EIR) from the ...

Dr. Reddy's Laboratories announced that its Active Pharmaceutical Ingredient (API) manufacturing facility in Middleburgh, New York, has received the Establishment Inspection Report (EIR) from the ...

Cipla to acquire 20% in iCaltech, Eraaya reviews FCCB terms, and Dr Reddy’s API plant in New York receives VAI status from USFDA after GMP inspection.

Discover how smart lab inventory management software helps modern labs track samples in real-time, reduce waste, ensure ...

The USFDA has classified the outcome of the inspection as ‘Voluntary Action Indicated’ (VAI) and has officially closed the ...

Pharmaceutical R&D and quality control face increasing demands for speed, scalability, and regulatory compliance – yet many ...